What a Good Peptide COA Should Include: 12 Non-Negotiables

Quick Answer: What a COA Is and Why It Matters

A COA is a document issued by the manufacturer or a third-party laboratory confirming that a specific batch was tested against stated specifications. GMP guidance describes a COA as identifying the material and its batch, listing each test performed with its acceptance limits and numerical results, and being dated and signed by authorized quality personnel.¹

For research peptides, the COA is usually the central quality document a lab receives. Researchers rarely see the manufacturing or batch records behind a peptide, so the COA is often the only direct evidence of what is in the vial. That puts a lot of weight on how complete it is.

Peptide COA content varies widely between suppliers. At one end is a batch-specific report from an independent lab, with the mass spectrum, the chromatogram, method details, and a signature. At the other is a one-page PDF with a product name and a purity percentage, and nothing that connects it to a lot, a method, or a laboratory. A manufacturer COA can be reliable. An independent result adds a separate check, but method quality, representative sampling and traceability still matter.

The 12 Non-Negotiables

Use these 12 checks as a practical review framework. They are not a universal legal checklist for every research reagent: sterility and endotoxin requirements depend on the product claim and intended experiment, and some details may appear in supporting documents.

1. Batch or Lot Number

A unique batch or lot number ties the COA to one production run, so it can be matched to the label on the vial in hand. This matters because test results describe a batch, not a product name: peptide content and the impurity profile can vary from one batch to the next, even for the same sequence.²

A COA without a batch number, or one reused across unrelated lots, says nothing reliable about the material you actually have, and it is a red flag. See why batch-specific COAs beat generic PDFs.

2. Peptide Name, Sequence, and CAS or Molecular Formula

The COA should state the full peptide name, the amino acid sequence including any terminal modifications, the molecular formula, the theoretical molecular weight, and a CAS number where one exists. These fields document what the supplier intended to make, and the rest of the report is checked against them: the theoretical molecular weight is the target for mass spectrometry, and the sequence gives context for interpreting the purity result.

Rely on these identifiers, not on a product or trade name. Marketing names are not standardized, can differ between suppliers, and say nothing about the exact sequence or salt form. If the sequence and molecular weight are missing, the identity result has nothing concrete to confirm.

3. Identity Confirmation by Mass Spectrometry

Mass spectrometry, typically LC-MS or MALDI-MS, confirms that the main component has the expected molecular weight.^{2, 3} The COA should report both the theoretical and the observed mass so the match can be checked rather than taken on trust, and including the spectrum itself is better still.

Matching intact mass supports identity, but it cannot prove sequence order or distinguish every isomer. Additional sequence or structural characterization may be needed when that distinction matters.

Identity and purity answer different questions. Identity asks “is this the right peptide?”; purity asks “how much of the detected material is that peptide?” A sample can be highly pure and still be the wrong compound, so a high purity result means little without identity confirmation.

4. Purity by HPLC With the Chromatogram

Purity is typically reported as an area percent from reversed-phase HPLC, one of the main HPLC modes used for peptides,⁴ with UV detection commonly at 210 to 220 nm. The area of the main peak is compared with the total area of all detected peaks.³

The chromatogram must accompany the number. It shows the peaks behind the calculation: how dominant the main peak is, how many impurity peaks there are, and whether any sit close to the main peak. A purity percentage on its own hides all of that. For more on the method, see the role of HPLC in peptide characterization.

Method details matter because the result depends on the conditions. The COA should list the column, mobile phases, gradient, flow rate, and detection wavelength. Purity values for the same sample can differ between buffer systems,⁵ and general chromatography standards such as USP <621> describe system suitability checks that show a method was performing properly when the result was generated.⁶

HPLC-UV area-percent purity only reflects detected, integrated signals under that method. It is not a measurement of water or total counter-ion content, which is why net peptide content is a separate element.⁵

5. Net Peptide Content

Net peptide content is the share of the powder that is actually peptide, separate from purity. Lyophilized peptides also contain water, residual solvents, salts, and counter-ions, and purified synthetic peptides are usually obtained as trifluoroacetate (TFA) salts. So a vial can be 99% pure by HPLC yet contain less peptide than its gross weight suggests.^{2, 7} AAPPTec notes that net peptide content commonly falls somewhere between about 50 and 90 percent, depending on purity, sequence, and the synthesis and purification method.²

It is typically measured by quantitative amino acid analysis, nitrogen content from elemental analysis, or UV spectrophotometry.^{2, 5} Without it, a solution prepared from the gross weight can contain noticeably less peptide than intended.

Check whether the result is a peptide mass fraction (%) or measured peptide amount (mg per vial). If the COA already states measured net mg per vial, do not apply the percentage correction a second time. A content method must also account for other substances that contribute to its signal.

6. Sterility Test Result

For material specified as sterile, the COA should name the sterility method, such as USP <71> membrane filtration or direct inoculation, and report the result. Sterility testing checks for viable bacteria and fungi.⁸ For material not specified as sterile, the relevant result is typically a microbial limits (bioburden) count, such as a USP <61> microbial enumeration test.⁹ Either result matters most for cell culture and other contamination-sensitive work.

A sterility pass does not replace endotoxin testing. Sterility looks for living organisms, while endotoxin is a bacterial residue that survives after the organisms are dead, so a sample can pass one test and fail the other.¹⁰ See sterility vs. endotoxin testing.

7. Endotoxin (LPS) Test Result

When endotoxin control matters to the experiment, the COA should report the endotoxin method, the numerical value in endotoxin units (EU), typically per mg, and the detection limit. Testing is commonly by Limulus amebocyte lysate (LAL) methods described in USP <85>.¹¹

Endotoxins are lipopolysaccharides (LPS) from the outer membrane of gram-negative bacteria. They are shed as bacteria grow and die, are highly heat-stable, and are not destroyed under regular sterilizing conditions, so they can persist in a sample that contains no viable organisms.^{10, 12}

This matters for research because endotoxin activates immune cells such as monocytes and macrophages and triggers the release of pro-inflammatory mediators.¹⁰ In cell-based work, an unnoticed endotoxin load can produce responses that are easy to mistake for an effect of the peptide.

8. Appearance and Physical Description

A short description, typically “white to off-white lyophilized powder,” gives a simple point of comparison on receipt. Many peptides are white to off-white, but expected appearance is product-specific; colored compounds such as copper-peptide complexes are exceptions.³ An unexpected color or a wet-looking, clumped cake is worth a question to the supplier.

Appearance is a sanity check, not a quality test. It cannot confirm identity or purity, and incorrect or impure material can look exactly like a normal white powder.

9. Date of Analysis and Date of Manufacture

Both dates should appear. The manufacture date shows when the batch was made; the analysis date shows when testing happened, which tells you how current the results are relative to the material in hand. GMP guidance also expects a release date and an expiry or retest date where applicable.¹

Undated reports should be approached cautiously. An undated COA cannot be placed in time, so there is no way to tell whether the results still describe the batch.

10. Testing Laboratory Identification

The testing lab’s name, address, and contact details should appear. ISO/IEC 17025 expects each test report to include the laboratory’s name and address, a unique report identification, the method used, and identification of the person or persons authorizing the report.¹³ A named lab can be contacted to confirm the report matches the batch, and a reader can judge whether it is independent of the supplier.

Where available, the COA should also state the lab’s accreditation. ISO/IEC 17025 sets requirements for the competence, impartiality, and consistent operation of testing and calibration laboratories, and accreditation bodies assess labs against it.¹⁴ Anonymous testing claims, or reports with no laboratory identified, provide limited accountability.

11. Storage and Handling Recommendations

The COA or accompanying documents should state peptide-specific storage conditions for dry material and, where supported, solutions. Cold, dry, protected storage and single-use solution aliquots are common starting points, but the temperature and usable storage period depend on the sequence, solvent, concentration and stability data.¹⁵

The guidance matters because peptides are sensitive to moisture, air, light, and repeated freeze-thaw cycles. Sequences containing Asp, Glu, Lys, Arg, or His tend to absorb moisture from the air, and those containing Cys, Met, or Trp are prone to oxidation.¹⁵ See lyophilized peptide storage.

12. Authorized Signature, Digital Identifier, or Verifiable Reference

A legitimate COA should show that the report was reviewed, approved, and released by an authorized person. GMP guidance expects certificates to be dated and signed by authorized quality personnel.¹ ISO/IEC 17025 test reports likewise identify who authorized them and carry a unique identification.¹³ Acceptable evidence includes an analyst signature, quality assurance approval, a digital authentication code, or a unique report number the issuing lab can confirm.

An unsigned PDF with no verification route should not be considered equivalent to a properly authorized COA. A signature and a verifiable reference tie the result to an accountable lab.

What to Do When a COA Is Missing Elements

First decide whether the missing item is required for the product claim and your experiment. Request essential identity, purity, batch and laboratory information before use; request additional microbial or stability evidence when the application needs it.

Weigh substance over appearance. Complete, verifiable data on a plain report beats a polished report with results missing. Asking against the specific batch number makes sure the answer applies to the material you actually received.

Why Third-Party Testing Changes the Picture

An independent laboratory provides a useful check on the supplier’s own results. Independence does not automatically make a method better or prove that a submitted sample represents every vial, so review the test scope, sample traceability and laboratory competence as well.

Robust documentation pairs the manufacturer’s COA with an independent lab report for the same batch. Check that the batch number on both documents matches the vial, and that the third-party report names its lab and carries its own reference number. Verified Peptides publishes batch-specific third-party reports in its Lab Reports archive.¹⁶ See in-house vs. third-party testing.

Frequently Asked Questions About Peptide COAs

All peptides discussed here are for research use only.

Key Takeaways

• Twelve checks help assess a COA and its supporting documents; apply microbial and storage requirements to the intended work.
• Identity by mass spectrometry and purity by HPLC with the chromatogram are the foundation; net content, sterility, endotoxin, batch ID, dates, lab, and a verifiable signature complete it.
• Purity, net content, sterility, and endotoxin each measure something different, and none substitutes for another.
• If a critical element is missing, including an unidentified testing lab, do not use the lot until resolved.
• The COA is often the only direct evidence of what is in the vial; read it carefully.

Review a supplier’s published COAs against this checklist before accepting a lot for your research.

References

1. US Food and Drug Administration / ICH. Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients (sections 11.2 impurity profiles and 11.4 certificates of analysis). fda.gov
2. AAPPTec. Peptide Quality: Frequently Asked Questions. peptide.com
3. Bachem. Quality Control of Amino Acids & Peptides: A Guide. Knowledge center. bachem.com
4. Mant CT, Chen Y, Yan Z, et al. HPLC analysis and purification of peptides. Methods in Molecular Biology. 2007;386:3-55. PMC7119934
5. Bachem. What does HPLC purity mean? FAQ. bachem.com
6. United States Pharmacopeia. General Chapter <621> Chromatography (system suitability). USP-NF. uspnf.com
7. Sikora K, Jaśkiewicz M, Neubauer D, Migoń D, Kamysz W. The role of counter-ions in peptides: an overview. Pharmaceuticals. 2020;13(12):442. PMC7761850
8. United States Pharmacopeia. General Chapter <71> Sterility Tests (harmonized with Ph. Eur. 2.6.1 and JP 4.06). USP-NF. usp.org
9. United States Pharmacopeia. General Chapter <61> Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests. USP-NF. usp.org
10. Magalhães PO, Lopes AM, Mazzola PG, Rangel-Yagui C, Penna TCV, Pessoa A Jr. Methods of endotoxin removal from biological preparations: a review. Journal of Pharmacy and Pharmaceutical Sciences. 2007;10(3):388-404. J Pharm Pharm Sci
11. United States Pharmacopeia. General Chapter <85> Bacterial Endotoxins Test. USP-NF. uspnf.com
12. Thundimadathil J. Controlling endotoxin contamination during peptide manufacturing. R&D World (originally in Controlled Environments), 2012. rdworldonline.com
13. National Institute of Standards and Technology, Office of Weights and Measures. ISO/IEC 17025 Crosswalk: Reporting the Results (clause 7.8.2.1 report contents). February 2018. nist.gov
14. International Organization for Standardization. ISO/IEC 17025:2017 General requirements for the competence of testing and calibration laboratories. iso.org
15. GenScript. Peptide Storage and Handling Guidelines. genscript.com
16. Verified Peptides. Lab Reports (batch-specific third-party test reports). verifiedpeptides.com